---
document_datetime: 2023-09-21 18:59:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/glyxambi-epar-all-authorised-presentations_en.pdf
document_name: glyxambi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.010847
conversion_datetime: 2025-12-28 02:17:53.806414
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU)Number    | (Invented) name   | Strength     | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                   | Pack size                         |
|------------------|-------------------|--------------|-----------------------|---------------------------|---------------------------------------|-----------------------------------|
| EU/1/16/1146/001 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 7 x 1 tablets (unit dose)         |
| EU/1/16/1146/002 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 10 x 1 tablets (unit dose)        |
| EU/1/16/1146/003 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 14 x 1 tablets (unit dose)        |
| EU/1/16/1146/004 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister                               | 28 x 1 tablets (unit              |
| EU/1/16/1146/005 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | (PVC/PVDC/alu) blister (PVC/PVDC/alu) | dose) 30 x 1 tablets (unit dose)  |
| EU/1/16/1146/006 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 60 x 1 tablets (unit dose)        |
| EU/1/16/1146/007 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 70 x 1 tablets (unit dose)        |
| EU/1/16/1146/008 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 90 x 1 tablets (unit dose)        |
| EU/1/16/1146/009 | Glyxambi          | 10 mg / 5 mg | Film-coated tablet    | Oral use                  | blister                               | 100 x 1 tablets                   |
| EU/1/16/1146/010 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister                               | 7 x 1 tablet (unit                |
| EU/1/16/1146/011 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | (PVC/PVDC/alu) blister (PVC/PVDC/alu) | dose)s 10 x 1 tablets (unit dose) |
| EU/1/16/1146/012 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 14 x 1 tablets (unit dose)        |
| EU/1/16/1146/013 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 28 x 1 tablets (unit dose)        |
| EU/1/16/1146/014 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 30 x 1 tablets (unit dose)        |
| EU/1/16/1146/015 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister                               | 60 x 1 tablets (unit              |
| EU/1/16/1146/016 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | blister                               | 70 x 1 tablets (unit              |
| EU/1/16/1146/017 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | (PVC/PVDC/alu) blister                | dose) 90 x 1 tablets (unit        |
| EU/1/16/1146/018 | Glyxambi          | 25 mg / 5 mg | Film-coated tablet    | Oral use                  | (PVC/PVDC/alu) blister (PVC/PVDC/alu) | dose) 100 x 1 tablets (unit dose) |